Retatrutide | 6mg
€115,00
Retatrutide is an experimental compound developed for the treatment of obesity and related metabolic diseases, such as type 2 diabetes. It is a multi-receptor agonist that regulates appetite and metabolism hormones in the body. The primary goal of Retatrutide is to support weight loss by reducing appetite, increasing satiety, and regulating glucose metabolism. The mechanism of action of Retatrutide involves interaction with three hormones: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic peptide), and glucagon. These hormones play a key role in controlling appetite, insulin secretion, and fat breakdown. Retatrutide is being viewed with great interest as part of a new generation of weight loss compounds being developed to offer more effective and long-lasting solutions for body weight control and metabolic diseases.
Key Benefits
Significant weight loss of up to 24% body weight with sustained therapy. Improves blood sugar control, particularly beneficial for type 2 diabetes management. Regulates appetite-related hormones and metabolism by activating GLP-1, GIP, and glucagon receptors. Reduces cardiovascular risk through weight reduction and improved metabolic profile. Improves lipid profile by lowering LDL cholesterol and triglycerides. Potential treatment for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Clinical Research
Clinical trials of Retatrutide have focused on investigating its efficacy for weight loss and treatment of metabolic diseases such as type 2 diabetes and obesity. Phase 1 assessed safety, tolerability, and initial efficacy. Significant effects on weight loss and appetite control were reported with gradual and sustained weight loss observed. Phase 2 investigated dosing and confirmed initial results. In these studies, weight loss between 15% and 24% has been documented after approximately 48 weeks of therapy, along with improvements in blood sugar indicators and insulin sensitivity. Dose-dependent effects have been observed, with higher doses showing better results but also increased frequency of gastrointestinal side effects. Phase 3 is confirming efficacy and safety in larger groups over longer periods, focusing on long-term benefits including cardiovascular risk reduction and liver function improvement in cases with NAFLD/NASH. Retatrutide continues to be investigated in various clinical trials to determine its long-term safety and efficacy.
Usage & Dosage
Dosage of Retatrutide varies depending on specific conditions; consultation with a qualified specialist is recommended for proper dose determination and administration method. Administered via subcutaneous injection once weekly. Initial dose is typically 2mg, which may be increased to 6mg or 8mg depending on conditions. If a dose is missed, it should be administered as soon as possible, but double doses should not be taken. Inject in the abdominal area or front of the thigh. After injection, wait 10 seconds before removing the needle. Rotation of injection sites is recommended. For 6mg pen: Contains 120 units of 50mcg each (1 unit = 50mcg, 10 units = 0.50mg, 20 units = 1mg, 30 units = 1.5mg, 40 units = 2mg). For 12mg pen: Contains 120 units of 100mcg each (1 unit = 100mcg, 10 units = 1mg, 20 units = 2mg, 25 units = 2.5mg, 40 units = 4mg, 60 units = 6mg).
Proper Storage
To ensure the optimal quality of our products, we pay special attention to the delivery and storage of peptides. All our shipments are sent in specialized cooling boxes that maintain the required temperature during transportation. This ensures that the products reach you in perfect condition. After receiving the peptides, it is important to store them properly to maintain their stability and effectiveness. We recommend storage at temperatures between 2°C and 8°C in a refrigerator. This guarantees that the peptides will retain their properties throughout their shelf life.
Important Information
For research purposes only. Not intended for human consumption. Requires refrigeration. Must be used under medical supervision. Possible side effects may include nausea, vomiting, diarrhea, constipation, fatigue, and slight increase in heart rate. Most side effects are mild and typically resolve within a few days as the body adapts. Consultation with a specialist is mandatory, and following their instructions and dosing will help prevent adverse reactions. Not for use during pregnancy or nursing.